UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group

Mueller, Sabine; Fangusaro, Jason; Thomas, Arzu Onar; Jacques, Thomas S; Bandopadhayay, Pratiti; de Blank, Peter; Packer, Roger J; ... Witt, Olaf; + view all (2024) Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group. Neuro-Oncology , 26 (3) pp. 407-416. 10.1093/neuonc/noad227. Green open access

[thumbnail of Jacques_Consensus framework for conducting phase I_II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma_AAM.pdf]
Preview
Text
Jacques_Consensus framework for conducting phase I_II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma_AAM.pdf

Download (282kB) | Preview

Abstract

Within the last few decades, we have witnessed tremendous advancements in the study of pediatric low-grade gliomas (pLGG), leading to a much-improved understanding of their molecular underpinnings. Consequently, we have achieved successful milestones in developing and implementing targeted therapeutic agents for treating these tumors. However, the community continues to face many unknowns when it comes to the most effective clinical implementation of these novel targeted inhibitors or combinations thereof. Questions encompassing optimal dosing strategies, treatment duration, methods for assessing clinical efficacy, and the identification of predictive biomarkers remain unresolved. Here, we offer the consensus of the international pLGG coalition (iPLGGc) clinical trial working group on these important topics and comment on clinical trial design and endpoint rationale. Throughout, we seek to standardize the global approach to early clinical trials (phase I and II) for pLGG, leading to more consistently interpretable results as well as enhancing the pace of novel therapy development and encouraging an increased focus on functional endpoints as well and quality of life for children faced with this disease.

Type: Article
Title: Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/neuonc/noad227
Publisher version: http://dx.doi.org/10.1093/neuonc/noad227
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: Consensus recommendation, Early phase clinical trial, Low grade glioma
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10185874
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item